BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen H. Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease. Liver Research 2020;4:15-22. [DOI: 10.1016/j.livres.2020.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu M, Chen H, Zhou S, Zheng L, Li X, Chu R, Chen W, Wang B, Wang M, Chai Z, Feng W. Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload. Nanotoxicology 2021;15:761-78. [PMID: 33961538 DOI: 10.1080/17435390.2021.1919329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Iacob SA, Iacob DG. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Front Endocrinol 2022;13:814209. [DOI: 10.3389/fendo.2022.814209] [Reference Citation Analysis]
3 Madatali Abuwani A, Priyadarshini Dash S, Ganesan R, Renu K, Vellingiri B, Kandasamy S, C R SR, Valsala Gopalakrishnan A. Gut microbiome and metabolic response in non-alcoholic fatty liver disease. Clin Chim Acta 2021;523:304-14. [PMID: 34666025 DOI: 10.1016/j.cca.2021.10.014] [Reference Citation Analysis]
4 Wen L, Li M, Lin X, Li Y, Song H, Chen H. AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD. Front Bioeng Biotechnol 2022;10:912178. [DOI: 10.3389/fbioe.2022.912178] [Reference Citation Analysis]
5 Zhou S, Li X, Zhu M, Yu H, Chu R, Chen W, Wang B, Wang M, Zheng L, Chai Z, Chen H, Feng W. Hepatic impacts of gold nanoparticles with different surface coatings as revealed by assessing the hepatic drug-metabolizing enzyme and lipid homeostasis in mice. NanoImpact 2020;20:100259. [DOI: 10.1016/j.impact.2020.100259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Reis-barbosa PH, Marcondes-de-castro IA, Marinho TDS, Aguila MB, Mandarim-de-lacerda CA. The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice. Clinics and Research in Hepatology and Gastroenterology 2022. [DOI: 10.1016/j.clinre.2022.101922] [Reference Citation Analysis]
7 Crawford DHG, Ross DGF, Jaskowski LA, Burke LJ, Britton LJ, Musgrave N, Briskey D, Rishi G, Bridle KR, Subramaniam VN. Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways. Biochim Biophys Acta Mol Basis Dis 2021;1867:166142. [PMID: 33839281 DOI: 10.1016/j.bbadis.2021.166142] [Reference Citation Analysis]